ACE2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACE2 monoclonal antibodies for research focused on understanding angiotensin-converting enzyme 2 (ACE2). ACE2 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACE2 is a crucial enzyme in the renin-angiotensin system, playing a significant role in regulating blood pressure and fluid balance. Research has shown ACE2 functions as a receptor for the SARS-CoV-2 virus, making it central to studies related to COVID-19 and cardiovascular health. Understanding ACE2's function and regulation continues to be a priority in developing therapeutic strategies for various diseases, including hypertension and respiratory infections. ACE2 expression has been detected in multiple organs, including the heart, kidneys, and lungs, highlighting its importance in various physiological processes. Recent studies have revealed new insights into ACE2's role in maintaining cardiovascular homeostasis and its potential as a therapeutic target. Ongoing research aims to uncover additional functions and regulatory mechanisms of ACE2 in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of ACE2 and its impact on human health.